Literature DB >> 18342392

Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption.

Shira Granot-Attas1, Ari Elson.   

Abstract

Osteoclasts are large cells derived from the monocyte-macrophage hematopoietic cell lineage. Their primary function is to degrade bone in various physiological contexts. Osteoclasts adhere to bone via podosomes, specialized adhesion structures whose structure and subcellular organization are affected by mechanical contact of the cell with bone matrix. Ample evidence indicates that reversible tyrosine phosphorylation of podosomal proteins plays a major role in determining the organization and dynamics of podosomes. Although roles of several tyrosine kinases are known in detail in this respect, little is known concerning the roles of protein tyrosine phosphatases (PTPs) in regulating osteoclast adhesion. Here we summarize available information concerning the known and hypothesized roles of the best-researched PTPs in osteoclasts - PTPRO, PTP epsilon, SHP-1, and PTP-PEST. Of these, PTPRO, PTP epsilon, and PTP-PEST appear to support osteoclast activity while SHP-1 inhibits it. Additional studies are required to provide full molecular details of the roles of these PTPs in regulating osteoclast adhesion, and to uncover additional PTPs that participate in this process.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18342392     DOI: 10.1016/j.ejcb.2008.01.006

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  9 in total

1.  Protein tyrosine phosphatase epsilon regulates integrin-mediated podosome stability in osteoclasts by activating Src.

Authors:  Shira Granot-Attas; Chen Luxenburg; Eynat Finkelshtein; Ari Elson
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

2.  TULA-2, a novel histidine phosphatase, regulates bone remodeling by modulating osteoclast function.

Authors:  Steven H Back; Naga Suresh Adapala; Mary F Barbe; Nick C Carpino; Alexander Y Tsygankov; Archana Sanjay
Journal:  Cell Mol Life Sci       Date:  2012-11-13       Impact factor: 9.261

Review 3.  A novel miR17/protein tyrosine phosphatase-oc/EphA4 regulatory axis of osteoclast activity.

Authors:  Kin-Hing William Lau; Matilda H-C Sheng
Journal:  Arch Biochem Biophys       Date:  2018-05-17       Impact factor: 4.013

4.  Chemical rescue of protein tyrosine phosphatase activity.

Authors:  Vincent L Chen; Anthony C Bishop
Journal:  Chem Commun (Camb)       Date:  2009-11-18       Impact factor: 6.222

5.  Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.

Authors:  Min Yu; Guang Lin; Niloofar Arshadi; Irina Kalatskaya; Bin Xue; Syed Haider; Francis Nguyen; Paul C Boutros; Ari Elson; Lakshmi B Muthuswamy; Nicholas K Tonks; Senthil K Muthuswamy
Journal:  Mol Cell Biol       Date:  2012-07-30       Impact factor: 4.272

Review 6.  Role of OSCAR Signaling in Osteoclastogenesis and Bone Disease.

Authors:  Iva R Nedeva; Mattia Vitale; Ari Elson; Judith A Hoyland; Jordi Bella
Journal:  Front Cell Dev Biol       Date:  2021-04-12

Review 7.  Protein tyrosine phosphatases in skeletal development and diseases.

Authors:  Huiliang Yang; Lijun Wang; Christian Shigley; Wentian Yang
Journal:  Bone Res       Date:  2022-01-28       Impact factor: 13.567

8.  Role of protein-tyrosine phosphatases in regulation of osteoclastic activity.

Authors:  M H-C Sheng; K-H W Lau
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.207

9.  Clinical Outcome 3 Years After Autologous Chondrocyte Implantation Does Not Correlate With the Expression of a Predefined Gene Marker Set in Chondrocytes Prior to Implantation but Is Associated With Critical Signaling Pathways.

Authors:  Johan Stenberg; Tommy S de Windt; Jane Synnergren; Lars Hynsjö; Josefine van der Lee; Daniel B F Saris; Mats Brittberg; Lars Peterson; Anders Lindahl
Journal:  Orthop J Sports Med       Date:  2014-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.